KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Net Income towards Common Stockholders: 2010-2025

Historic Net Income towards Common Stockholders for Dynavax Technologies (DVAX) over the last 16 years, with Sep 2025 value amounting to $28.2 million.

  • Dynavax Technologies' Net Income towards Common Stockholders rose 49.24% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.9 million, marking a year-over-year decrease of 277.80%. This contributed to the annual value of $27.3 million for FY2024, which is 527.44% up from last year.
  • Per Dynavax Technologies' latest filing, its Net Income towards Common Stockholders stood at $28.2 million for Q3 2025, which was up 41.13% from $20.0 million recorded in Q2 2025.
  • Dynavax Technologies' 5-year Net Income towards Common Stockholders high stood at $128.8 million for Q2 2022, and its period low was -$96.1 million during Q1 2025.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was $7.0 million (2024), whereas its average is -$2.1 million.
  • As far as peak fluctuations go, Dynavax Technologies' Net Income towards Common Stockholders skyrocketed by 14,350.62% in 2022, and later slumped by 1,001.93% in 2025.
  • Quarterly analysis of 5 years shows Dynavax Technologies' Net Income towards Common Stockholders stood at $99.8 million in 2021, then tumbled by 32.12% to $67.7 million in 2022, then plummeted by 99.68% to $219,000 in 2023, then spiked by 3,119.18% to $7.0 million in 2024, then soared by 49.24% to $28.2 million in 2025.
  • Its Net Income towards Common Stockholders was $28.2 million in Q3 2025, compared to $20.0 million in Q2 2025 and -$96.1 million in Q1 2025.